Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 1990BloodOpen Access

High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy

View Full Paper
Ask AI
Bookmark
Share

Authors

RBR.A. BrownLinde (United States)RHRH HerzigNational Institutes of HealthSWSN WolffAastrom Biosciences (United States)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Brown et al. (1990) studied this question.

synapsesocial.com/papers/6a7162a18031ec7bb1dcef97https://doi.org/10.1182/blood.v76.3.473.bloodjournal763473
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation1989 · 9 citations
  2. 2High-dose cytosine arabinoside therapy for refractory leukemia1983 · 15 citations
  3. 3High-dose VP-16-213 and autologous bone marrow transplantation for refractory malignancies: a phase I study.1983 · 107 citations